GlucoFriend-evaluation the Effectiveness of Glucobay When Combined With a Basal Insulin

To evaluate the effectiveness of Glucobay when combined with a basal insulin under daily-life treatment conditions in a large sample of Korean patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Many Locations, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Signed written informed consent
Age ≥ 18 years
Diagnosed of type 2 diabetes for at least 6 months prior to enrollment
Patients treated with stable dose of a basal insulin (insulin glargine or insulin detemir) at least 2 months
HbA1C≥7.5 and ≤10.0%

Exclusion criteria

Exclusion criteria must be read in conjunction with the local product information

Treatment and study plan

Acarbose (Glucobay, BAYG5421)

Drug

Adult female and male patients are scheduled to be treated with acarbose will be enrolled after the therapy decision has been made. Physicians should consult the full prescribing information for Glucobay® before enrolling patients and familiarize themselves with the safety information in the product package label.

Primary outcomes

Change in HbA1c

Time frame: After 20 weeks

Secondary outcomes

Duration and dose of acarbose treatment

Time frame: After 20 weeks
Postprandial Blood Glucose

Time frame: After 20 weeks

Sponsors and collaborators

Lead sponsor

Bayer

Industry

Registry information

Official study title

Combined Use of a Basal Insulin and Glucobay For Reducing PPG to End Diabetes Progress

Important dates

Study start: 2010
Study completion: 2012
First posted: Nov 25, 2010
Registry last updated: Jun 20, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed